Maternal pertussis vaccination programme

From 1 July 2024, ADACEL(Tdap), a non-IPV-containing vaccine, will replace Boostrix-IPV (dTaP/IPV) for the pertussis vaccination in pregnancy programme. The Joint Committee on Vaccination and Immunisation recognises the importance of vaccinating pregnant women to protect their babies from pertussis and the advice is that Boostrix-IPV vaccine should still be given if ADACEL is not available to avoid delays in vaccination. This letter provides information to practices, commissioners and other healthcare professionals.

Keep up to date

Sign up to receive our daily news alerts straight to your inbox. Subscribe to our weekly newsletter containing a summary of the week’s news, blog and vote on our poll.

Have a discussion

Help keep the conversation going between meetings by creating a forum to hold discussions with your members. It’s an easy way to manage and communicate with members.

Create a network

Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.

Networks can be open to all or available only to a closed group defined by the administrator.

Join or create a network here.